GoodRx Holdings, Inc. – NASDAQ:GDRX

Add to watchlist

$4.69

+0.07

+1.52%

Market closed

Open in about 11 hours

-40.08%

month

-40.08%

quarter

-29.03%

year

Market Cap	1.69B
Enterprise value	1.69B

P/E	-72.62
EV/Sales	2.91
EV/EBITDA	40.02
Price/Sales	4.10
Price/Book	2.93
PEG ratio	2.17
EPS	-0.01

Revenue	764.15M
EBITDA	108.97M
Income	-6.58M
Revenue Q/Q	7.55%
Revenue Y/Y	2.26%

Profit margin	-5.3%
Oper. margin	0%
Gross margin	91.81%
EBIT margin	0%
EBITDA margin	14.26%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

GoodRx Holdings, Inc. (NASDAQ:GDRX): Profit margin
Jun 2023	189.67M	58.78M	30.99%
Sep 2023	179.95M	-38.49M	-21.39%
Dec 2023	196.64M	-25.86M	-13.16%
Mar 2024	197.88M	-1.00M	-0.51%

GoodRx Holdings Financials Estimate

Q Y

GoodRx Holdings, Inc. (NASDAQ:GDRX): Analyst Estimates
Sep 2025	214.98M	47.47M	22.08%
Oct 2025	222.92M	44.80M	20.1%
Dec 2025	227.35M	46.85M	20.61%
Mar 2026	239.11M	63.48M	26.55%

Analysts Price target
Financials & Ratios estimates

GoodRx Holdings, Inc. (NASDAQ:GDRX): Earnings per share (EPS)
2024-02-29	0.08	0.08

GoodRx Holdings, Inc. (NASDAQ:GDRX): Debt to assets
Jun 2023	1692102000	796.73M	47.09%
Sep 2023	1707972000	826.69M	48.4%
Dec 2023	1588800000	826.84M	52.04%
Mar 2024	1453963000	822.89M	56.6%

GoodRx Holdings, Inc. (NASDAQ:GDRX): Cash Flow
Jun 2023	29.86M	-14.95M	-13.99M
Sep 2023	60.27M	-13.64M	-13.70M
Dec 2023	15.86M	-12.87M	-125.60M
Mar 2024	42.58M	-20.61M	-160.97M

GoodRx Holdings alternative data

GoodRx Holdings, Inc. (NASDAQ:GDRX): Employee count
Sep 2023	952
Oct 2023	952
Nov 2023	952
Dec 2023	952
Jan 2024	952
Feb 2024	952
Mar 2024	694
Apr 2024	694
May 2024	694
Jun 2024	694
Jul 2024	694

GoodRx Holdings
Hedge Funds Holdings Q3 2022

33.03% -3.16%

of GDRX is owned by hedge funds

151 -9

hedge funds hold GDRX stock

136.12M -18.54M

shares is hold by hedge funds

GDRX hedge funds holdings changes

GoodRx Holdings
Insider Trading

GoodRx Holdings, Inc. (NASDAQ:GDRX): Insider trades (number of shares)
Period	Buy	Sel
Nov 2023	182900	0
Aug 2024	0	79000
Sep 2024	0	3849

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	21 Dec 2024	KENNEDY KELLY J. director director	Restricted Stock Unit	23,150	N/A	N/A
Option	21 Dec 2024	KENNEDY KELLY J. director director	Class A Common Stock	23,150	$4.44	$102,786
Option	8 Dec 2024	VOERMANN KARSTEN officer: Chief Financial Officer officer: Chief Financial Officer	Restricted Stock Unit	54,064	N/A	N/A
Option	8 Dec 2024	WAGNER SCOTT officer: See Remarks officer: See Remarks	Class A Common Stock	70,591	N/A	N/A
Option	8 Dec 2024	WAGNER SCOTT officer: See Remarks officer: See Remarks	Restricted Stock Unit	70,591	N/A	N/A
Option	8 Dec 2024	VOERMANN KARSTEN officer: Chief Financial Officer officer: Chief Financial Officer	Class A Common Stock	54,064	N/A	N/A
Option	8 Dec 2024	NABIEY ROMIN officer: Chief Accounting Officer officer: Chief Accounting Officer	Class A Common Stock	10,200	N/A	N/A
Option	8 Dec 2024	NABIEY ROMIN officer: Chief Accounting Officer officer: Chief Accounting Officer	Class A Common Stock	2,232	N/A	N/A
Option	8 Dec 2024	NABIEY ROMIN officer: Chief Accounting Officer officer: Chief Accounting Officer	Restricted Stock Unit	10,200	N/A	N/A
Option	8 Dec 2024	NABIEY ROMIN officer: Chief Accounting Officer officer: Chief Accounting Officer	Restricted Stock Unit	2,232	N/A	N/A

GDRX insider trading transactions

GoodRx Holdings
Earnings Call Transcripts

Quarter	Transcript
Q1 2024 9 May 2024	Q1 2024 Earnings Call Transcript
Q4 2023 29 Feb 2024	Q4 2023 Earnings Call Transcript
Q3 2023 9 Nov 2023	Q3 2023 Earnings Call Transcript
Q2 2023 9 Aug 2023	Q2 2023 Earnings Call Transcript

GDRX earnings call transcripts

GoodRx Holdings
Executives

Insider	Age	Compensation
Mr. Trevor Bezdek (1978) Co-founder, Co-Chief Executive Officer, Sec. & Director	47	$989,960
Mr. Douglas Joseph Hirsch (1971) Co-founder, Co-Chief Executive Officer & Director	54	$987,710
Mr. Bansi Nagji (1965) Pres of Healthcare	60	$562,010
Mr. Andrew Slutsky (1987) Pres of Consumer	38	$546,520

GoodRx Holdings
Latest News

Wednesday, 18 December 2024
16:05	GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference	businesswire.com
Monday, 16 December 2024
16:05	GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer	businesswire.com
Thursday, 5 December 2024
09:00	Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says	cnbc.com
09:00	GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged	businesswire.com
Tuesday, 3 December 2024
16:32	GoodRx initiated with a Neutral at Mizuho	https://thefly.com
Monday, 18 November 2024
09:00	GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity Scholarship	businesswire.com
Wednesday, 13 November 2024
12:38	Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm	prnewswire.com
Tuesday, 12 November 2024
21:00	GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	globenewswire.com
Friday, 8 November 2024
07:15	Why GoodRx Holdings Stock Was Sinking This Week	fool.com
Thursday, 7 November 2024
14:14	GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript	seekingalpha.com
10:35	GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates	zacks.com
08:26	GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates	zacks.com
06:05	GoodRx Reports Third Quarter 2024 Results	businesswire.com
Wednesday, 6 November 2024
10:20	GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates	zacks.com
Tuesday, 5 November 2024
15:44	GoodRx and CVS Sued for Suppressing Pharmacy Reimbursement	pymnts.com
Monday, 4 November 2024
16:05	GoodRx to Participate in Upcoming Investor Conferences	businesswire.com
Thursday, 31 October 2024
15:17	Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm	globenewswire.com
Wednesday, 23 October 2024
09:00	GoodRx Announces New Affordability Programs for Menopause Hormone Therapies	businesswire.com
Thursday, 10 October 2024
17:41	GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call	businesswire.com
Tuesday, 8 October 2024
14:46	GoodRx Holdings: Failing To Gain Much Traction	seekingalpha.com
12:48	ELV vs. GDRX: Which Stock Is the Better Value Option?	zacks.com
Thursday, 26 September 2024
09:00	GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)	businesswire.com
Wednesday, 25 September 2024
21:00	GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	globenewswire.com
Thursday, 8 August 2024
16:01	GoodRX Subscription Revenue Down 8% but Active User Numbers Are Up	pymnts.com
13:07	GoodRx Holdings, Inc. (GDRX) Q2 2024 Earnings Call Transcript	seekingalpha.com
12:04	GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges	benzinga.com
10:35	GoodRx (GDRX) Reports Q2 Earnings: What Key Metrics Have to Say	zacks.com
08:20	GoodRx Holdings, Inc. (GDRX) Misses Q2 Earnings and Revenue Estimates	zacks.com
06:05	GoodRx Reports Second Quarter 2024 Results	businesswire.com
Tuesday, 6 August 2024
10:20	Unveiling GoodRx (GDRX) Q2 Outlook: Wall Street Estimates for Key Metrics	zacks.com

Ideas & Opinions

Seeking Alpha 18 Aug 2025

GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?
Seeking Alpha 18 Aug 2025

Novo Nordisk's Loss Is Eli Lilly's Gain, And Vice Versa
Seeking Alpha 8 Jul 2025

GoodRx: A One Big Beautiful Bill Act Beneficiary
Seeking Alpha 6 Jun 2025

GoodRx: Stabilizing Revenue Amid Healthy Profit Gains
Seeking Alpha 23 Jan 2024

GoodRx: Cost Saving Is A Strong Value Proposition To Consumers
Seeking Alpha 27 Sep 2023

GoodRx Faces Challenges In Subscription Plans, But Its Valuation Already Prices This In
Seeking Alpha 26 Sep 2023

GoodRx Stock: Earnings Momentum Keeps It Interesting
Seeking Alpha 24 Jul 2023

GoodRx Holdings: Stay Cautious In FY23 Until Clear Signs Of Growth Inflection Appear
Seeking Alpha 20 Jun 2023

GoodRx's Integrative Growth Strategy Inches Towards Sustained Profitability
Seeking Alpha 20 Jun 2023

GoodRx: New Leadership May Set Up This Struggling Company For Success

Frequently Asked Questions (FAQ)

What's the price of GoodRx Holdings stock today?

One share of GoodRx Holdings stock can currently be purchased for approximately $4.69.
When is GoodRx Holdings's next earnings date?

Unfortunately, GoodRx Holdings's (GDRX) next earnings date is currently unknown.
Does GoodRx Holdings pay dividends?

No, GoodRx Holdings does not pay dividends.
How much money does GoodRx Holdings make?

GoodRx Holdings has a market capitalization of 1.69B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2.12% to 750.27M US dollars. GoodRx Holdings made a loss 8.87M US dollars in net income (profit) last year or $0.08 on an earnings per share basis.
What is GoodRx Holdings's stock symbol?

GoodRx Holdings, Inc. is traded on the NASDAQ under the ticker symbol "GDRX".
What is GoodRx Holdings's primary industry?

Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
How do i buy shares of GoodRx Holdings?

Shares of GoodRx Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are GoodRx Holdings's key executives?
GoodRx Holdings's management team includes the following people:
- Mr. Trevor Bezdek Co-founder, Co-Chief Executive Officer, Sec. & Director(age: 47, pay: $989,960)
- Mr. Douglas Joseph Hirsch Co-founder, Co-Chief Executive Officer & Director(age: 54, pay: $987,710)
- Mr. Bansi Nagji Pres of Healthcare(age: 60, pay: $562,010)
- Mr. Andrew Slutsky Pres of Consumer(age: 38, pay: $546,520)
Is GoodRx Holdings founder-led company?

Yes, GoodRx Holdings is a company led by its founders Mr. Trevor Bezdek and Mr. Douglas Joseph Hirsch.
How many employees does GoodRx Holdings have?

As Jul 2024, GoodRx Holdings employs 694 workers.
When GoodRx Holdings went public?

GoodRx Holdings, Inc. is publicly traded company for more then 5 years since IPO on 23 Sep 2020.
What is GoodRx Holdings's official website?

The official website for GoodRx Holdings is goodrx.com.
Where are GoodRx Holdings's headquarters?

GoodRx Holdings is headquartered at 2701 Olympic Boulevard, Santa Monica, CA.
How can i contact GoodRx Holdings?

GoodRx Holdings's mailing address is 2701 Olympic Boulevard, Santa Monica, CA and company can be reached via phone at +855 2682822.

GoodRx Holdings, Inc.

goodrx.com

Exchange:

NASDAQ

Full time employees:

694

Industry:

Medical - Healthcare Information Services

Sector:

Healthcare

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.

+855 2682822

2701 Olympic Boulevard
Santa Monica, CA 90404

CIK: 0001809519
ISIN: US38246G1085
CUSIP: 38246G108